Hikma v. Amarin: What the Supreme Court’s Decision Means for Pleading Induced Infringement
On June 4, 2026, the US Supreme Court unanimously decided Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., holding that induced patent infringement under § 271(b) requires a plaintiff to plausibly allege affirmative steps to encourage infringement, …